Elizabeth A. Brown

Risk Factors for <i>Clostridium difficile</i> Toxin-Associated Diarrhea

Elizabeth A. Brown, George H. Talbot, Peter Axelrod et al. · Infection Control and Hospital Epidemiology · 1990 · 181 citations

Toxinology, Hospital-wide Attack Rate, Drug Resistance +19

Quantification of the Degradation Products of Sevoflurane in Two CO2 Absorbants during Low-flow Anesthesia in Surgical Patients

Edward J. Frink, T. Philip Malan, Scott E. Morgan et al. · Anesthesiology · 1992 · 173 citations · Full text

Co2 Absorbants, Medicine, Sevoflurane Degradation Products +14

Optimally functional fluorescein isothiocyanate‐labelled fibrinogen for quantitative studies of binding to activated platelets and platelet aggregation

Z. Xia, Tit-Yee Wong, Qingde Liu et al. · British Journal of Haematology · 1996 · 82 citations

Pharmacological studies with SK&amp;F 93944 (temelastine), a novel histamine H₁‐receptor antagonist with negligible ability to penetrate the central nervous system

Elizabeth A. Brown, R R Griffiths, Carol Harvey et al. · British Journal of Pharmacology · 1986 · 62 citations · Full text

Pharmacotherapy, Experimental Pharmacology, Histamine Tachycardia +16

Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)

Allan Gaw, Heather Murray, Elizabeth A. Brown · Atherosclerosis · 2005 · 38 citations

Metabolic Syndrome, Cardiovascular Epidemiology, Aging +11